| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Robert Thomas Freeman last filed a Form 4 in March 2025, as Chief Financial Officer at ALHC. Robert Thomas Freeman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Robert Thomas Freeman's trades have earned a middling insider score of 58/100 across 44 rated trades. Over a 12-month horizon, 47.7% of those trades were profitable, with an average 12-month return of -2.9%.
At the last filing, the largest reported position was 1,464,419 shares of ALHC. The ALHC filings lean toward selling, a net 1,376,173 shares.
Robert Thomas Freeman has 35 Form 4 filings on record from March 2021 to March 2025, all as Chief Financial Officer at Alignment Healthcare (ALHC), 2021–2025.
The 60 reported transactions were 49 open-market sales, 8 stock awards and 3 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 32 sales worth about $19.1M.
The largest open-market sale was 468,295 shares of ALHC at an average $15.56 on March 6, 2025, about $7.3M. Twelve months later ALHC was up 21%.
9 of the 15 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 6 were not.
Shares as reported in the last Form 4 for each company; the most recent is from March 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | ALHC Alignment Healthcare, Inc. | Chief Financial Officer | Sell | 6,744 | $17.89 | $120,650.16 | -0.5% | -24.4% | -8.3% | |
| Mar 19, 2025 | ALHC Alignment Healthcare, Inc. | Chief Financial Officer | Sell | 25,247 | $16.67 | $420,838.90 | -1.7% | -15.2% | +5.6% | |
| Mar 12, 2025 | ALHC Alignment Healthcare, Inc. | Chief Financial Officer | Sell | 14,692 | $15.43 | $226,661.66 | -1.0% | -6.7% | +9.0% | |
| Mar 6, 2025 | ALHC Alignment Healthcare, Inc. | Chief Financial Officer | Sell10b5-1 | 468,295 | $15.56 | $7,285,896.35 | -24.8% | +0.5% | +20.9% | |
| Nov 11, 2024 | ALHC Alignment Healthcare, Inc. | Chief Financial Officer | Sell10b5-1 | 30,500 | $13.42 | $409,355.75 | -24.7% | +7.2% | +22.4% | |
| Oct 31, 2024 | ALHC Alignment Healthcare, Inc. | Chief Financial Officer | Sell10b5-1 | 40,680 | $12.04 | $489,838.08 | -24.8% | +23.5% | +36.0% | |
| Oct 14, 2024 | ALHC Alignment Healthcare, Inc. | Chief Financial Officer | Sell10b5-1 | 30,500 | $11.50 | $350,872.00 | -15.7% | +18.5% | +51.5% | |
| Oct 8, 2024 | ALHC Alignment Healthcare, Inc. | Chief Financial Officer | Sell10b5-1 | 39,320 | $12.04 | $473,349.89 | -16.8% | -3.4% | +50.9% | |
| Oct 2, 2024 | ALHC Alignment Healthcare, Inc. | Chief Financial Officer | Sell10b5-1 | 30,500 | $10.76 | $328,256.17 | -11.5% | -0.1% | +42.5% | |
| Sep 13, 2024 | ALHC Alignment Healthcare, Inc. | Chief Financial Officer | Sell10b5-1 | 143,561 | $11.05 | $1,585,755.26 | -35.2% | -6.5% | +34.9% |